Left to Right, Lei Zhu and MAJ Kelly Ray, both Clinical Research Coordinators with the Walter Reed Army Institute, Clinical Trials Center prepare samples prior to the RV575 Research study, Sept. 27. In October, the Military HIV Research Program will launch the phase 1 study, evaluating varying doses of the Army's novel ALFQ adjuvant in a candidate HIV vaccine to determine the optimal adjuvant dosage level.

---

Size: 8192px × 5464px
Photo credit: © Operation 2022 / Alamy / Afripics
License: Licensed
Model Released: No

Keywords: ctc, hiv, research, study, wrair